Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 5, 2021 - Issue 1
Journal homepage
1,035
Views
14
CrossRef citations to date
0
Altmetric
Case Reports

Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies

Shin-ichiro Ohmuraa Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, JapanView further author information
,
Toru Yamabeb Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan;c Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, JapanView further author information
&
Taio Naniwab Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan;c Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0489-2611View further author information
ORCID Icon
Pages 76-81 | Received 29 May 2020, Accepted 12 Aug 2020, Published online: 14 Sep 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kareem G Elhage, Raymond Zhao & Mio Nakamura. (2022) Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature. Clinical, Cosmetic and Investigational Dermatology 15, pages 1815-1831.
Read now

Articles from other publishers (13)

Masahiro Yasui, Taro Iwamoto & Shunsuke Furuta. (2024) New therapies in anti-MDA5 antibody-positive dermatomyositis. Current Opinion in Rheumatology 36:1, pages 61-68.
Crossref
Yanhua Wang, Jing Luo, Xiaohong Lv, Yuanyuan Li, Qi An, Lingfei Mo, Nan Hu, Jing Zhang, Jing Wang, Juan Tian, Dan Pu, Zhiming Hao & Lan He. (2023) Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis. Clinical Rheumatology 42:7, pages 1847-1853.
Crossref
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki & Hiroshi Nakajima. (2023) Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD Open 9:1, pages e002795.
Crossref
Jantima Tanboon & Ichizo Nishino. (2022) Update on dermatomyositis. Current Opinion in Neurology 35:5, pages 611-621.
Crossref
Zhaoling Wang, Qi Zheng, Wenjie Xuan, Xisheng Xu, Meiping Lu, Jianqiang Wu, Lixia Zou, Yiping Xu & Xuefeng Xu. (2022) Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis. Frontiers in Pediatrics 10.
Crossref
Melody P. Chung & Julie J. Paik. (2022) Past, Present, and Future in Dermatomyositis Therapeutics. Current Treatment Options in Rheumatology 8:4, pages 71-90.
Crossref
Vijay Kodumudi, Lorin A. Bibb, Jonas A. Adalsteinsson, Neda Shahriari, Lauren Skudalski, Sueheidi Santiago, Jane M. Grant-Kels & Jun Lu. (2022) Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma. Journal of the American Academy of Dermatology 87:1, pages 21-38.
Crossref
Mark Garton & Clive Kelly. (2022) Is Janus Kinase Inhibition the Future of the Management of Rheumatoid Arthritis-associated Interstitial Lung Disease?. US Respiratory & Pulmonary Diseases 7:2, pages 38.
Crossref
A. Selva-O’Callaghan, F. Romero-Bueno, E. Trallero-Araguás, A. Gil-Vila, J. C. Ruiz-Rodríguez, O. Sánchez-Pernaute & I. Pinal-Fernández. (2021) Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease. Current Treatment Options in Rheumatology 7:4, pages 319-333.
Crossref
Aliza Paudyal, Ming Zheng, Ling Lyu, Christina Thapa, Shirui Gong, Yao Yang & Xiaoyan Lyu. (2021) JAK‐inhibitors for dermatomyositis: A concise literature review . Dermatologic Therapy 34:3.
Crossref
Caterina Vacchi, Andreina Manfredi, Giulia Cassone, Stefania Cerri, Giovanni Della Casa, Dario Andrisani, Carlo Salvarani & Marco Sebastiani. (2021) Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis. Case Reports in Medicine 2021, pages 1-5.
Crossref
Tomoyuki Fujisawa. (2021) Management of Myositis-Associated Interstitial Lung Disease. Medicina 57:4, pages 347.
Crossref
. (2021) Immunosuppressants/tofacitinib. Reactions Weekly 1852:1, pages 233-233.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.